Breast cancer therapeutic & market analysis assesses marketed and investigational products and combination regimens for the global breast cancer therapeutics market. Segmentation by drug class is provided, along with supporting information, such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology. Marketed and pipeline products are broadly segmented into hormonal therapy, targeted therapy, chemotherapy, and other therapies of current global interest. Cancer treatment involves various methods depending upon type and severity of cancer. Cancer treatment market is growing at a significant rate due to increase in the incidence of cancer cases, growing awareness among people about various stages and availability of treatment of cancer. The global breast cancer drugs market is anticipated to gain substantial growth over the forecast period owing to rising prevalence of breast cancer globally, emerging novel therapies, and integration of these therapies with advancement in imaging technologies. On the basis of treatment, the global breast cancer drugs market is divided into chemotherapy, surgery & radiation therapy, targeted therapy, and hormonal therapy.